Fucoidan may protect lungs from damage due to viral infection, says review of research
A recent review summarized the current research on marine polysaccharide fucoidan and its potential to limit lung damage from viral respiratory infections.
Photo © Stock.adobe.com/pickup
A recent review published in Marine Drugs1 summarizes the current research on marine polysaccharide fucoidan and its potential to limit lung damage from viral respiratory infections. Fucoidan is a highly bioactive compound found in brown seaweeds. The review is relevant because respiratory viral infections, such as that of COVID-19, can cause both acute and chronic damage to the lungs.
According to the review, current research shows that fucoidan has the potential to support innate immunity and inflammation in both clinical and animal models, and recent animal models have shown that fucoidan may attenuate pulmonary damage from acute viral infection. This represents a good foundation for further clinical research into the efficacy of fucoidan to protect lungs from damage associated with viral infection.
“The preservation of lung function and the limiting of lung damage may benefit individual patients and global health systems currently under immense strain,” said Marinova’s chief scientist and the lead author of the paper, Helen Fitton, PhD, in a press release. “Marinova is continuing to explore this potential with additional studies investigating immune function.”
Judge denies CRN’s motion for preliminary injunction but its lawsuit against NY state will proceed
April 23rd 2024The judge in CRN's lawsuit against NY state's law banning the sale of weight management and muscle building supplements to minors has denied its motion for a preliminary injunction, but determined that CRN has standing to sue on behalf of its members.
Arla Foods to acquired whey nutrition business from Volac International
April 22nd 2024Arla Foods Ingredients has reached an agreement to acquire Volac’s Whey Nutrition business through a purchase of shares in Volac Whey Nutrition Holdings Limited and its subsidiary, Volac Whey Nutrition Limited and Volac Renewable Energy Limited.
